Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0002022345-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-03 | 2025-09-01 | BIO | BARRY JAMES | EVP, Pres, LSG | M - OptEx | $0.00 | +602 | 748.56 | +411% | $0 |
| D | 2025-09-03 | 2025-09-01 | BIO | BARRY JAMES | EVP, Pres, LSG | F - Tax | $297.88 | -217 | 531.56 | -29% | -$64.6K |
| DM | 2025-09-03 | 2025-09-01 | BIO | BARRY JAMES | EVP, Pres, LSG | M - OptEx | $0.00 | -602 | 502 | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2025-09-01 | M | A | 602 | $0.00 | 748.56 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2025-09-01 | F | D | 217 | $297.88 | 531.56 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 174 | $0.00 | 174 | D | $0.00 · — to — | 174 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 4 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 178 | $0.00 | 0 | D | $0.00 · — to — | 178 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 5 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 250 | $0.00 | 502 | D | $0.00 · — to — | 250 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |